ACRV Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $47,368,750.00
Insider Selling (Last 12 Months): $0.00

Acrivon Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Acrivon Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Acrivon Therapeutics Share Price & Price History

Current Price: $12.65
Price Change: Price Increase of +0.15 (1.20%)
As of 12/2/2022 09:59 PM ET

This chart shows the closing price history over time for ACRV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Acrivon Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2022Ltd ChioneMajor ShareholderBuy400,000$12.50$5,000,000.003,856,597View SEC Filing Icon  
11/17/2022Ra Capital Management, L.P.DirectorBuy3,389,500$12.50$42,368,750.004,384,206View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Acrivon Therapeutics (NASDAQ:ACRV)

Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops precision oncology medicines. The company's lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1/2 for use in the treatment of platinum-resistant ovarian cancer; endometrial and bladder cancer; and SCCs, including SCCHN, cervical, and anal cancer. It is also developing two preclinical drug programs used to predict tumor sensitivity based on custom OncoSignature tests. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
Read More on Acrivon Therapeutics

Today's Range

Now: $12.65
Low: $12.40
High: $12.74

50 Day Range


52 Week Range

Now: $12.65
Low: $10.90
High: $20.70


17,500 shs

Average Volume

100,525 shs

Market Capitalization

$263.88 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Acrivon Therapeutics?

Acrivon Therapeutics' top insider shareholders include:
  1. Ra Capital Management, LP (Director)
  2. Ltd Chione (Major Shareholder)
Learn More about top insider investors at Acrivon Therapeutics.